Avalia Immunotherapies
2015
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$2.07M
LATEST DEAL AMOUNT
3
INVESTORS
Description
Developer of immunotherapies that support the treatment of cancer. The company's immunotherapies support the treatment of cancer, influenza, allergy, and other diseases. It also offers therapeutic vaccines that are intended for activating immune cells in the body.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Other Healthcare Services
Therapeutic Devices
Primary Office
- 69 Gracefield Road
- Lower Hutt, 5040
- New Zealand
+64 04-566 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Avalia Immunotherapies’s full profile, request a free trial.
Avalia Immunotherapies Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 10-May-2016 | $2.07M | 00.000 | Completed | Startup | |
| 1. Accelerator/Incubator | 21-May-2015 | 00000 | 00000 | Completed | Startup |
Avalia Immunotherapies Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| New Zealand Venture Investment Fund | Fund of Funds | Minority | 000 0000 | 000000 0 | ||
| Callaghan Innovation | Accelerator/Incubator | 000 0000 | 000000 0 | |||
| Powerhouse Ventures (Christchurch) | Venture Capital | Minority | 000 0000 | 000000 0 |
Avalia Immunotherapies Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Shivali Gulab Ph.D | Chief Executive Officer | ||
| Gavin Painter Ph.D | Chief Technology Officer | ||
| Ian Hermans Ph.D | Chief Scientific Officer |
Avalia Immunotherapies Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ashley Dunn Ph.D | Avalia Immunotherapies | Chairman | 000 0000 | |
| Colin Dawson | Powerhouse Ventures (Christchurch) | Board Member | 000 0000 | |
| Graham Le Gros MD | Avalia Immunotherapies | Board Member | 000 0000 | |
| Melissa Yiannoutsos | Avalia Immunotherapies | Board Member | 000 0000 | |
| Richard Furneaux Ph.D | Avalia Immunotherapies | Board Member | 000 0000 |